0.00Open0.00Pre Close0 Volume0 Open Interest37.50Strike Price0.00Turnover308.18%IV-136.59%PremiumMay 16, 2025Expiry Date21.65Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8797Delta0.0219Gamma0.72Leverage Ratio-0.0657Theta-0.0095Rho-0.63Eff Leverage0.0061Vega
RxSight Stock Discussion
RxSight Cuts 2025 Revenue Target by $25M Despite Strong Lens Sales Growth
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...
No comment yet